Metabolomics and cellular altered pathways in cancer biology: A review
- 15 August 2024
- journal article
- review article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 38 (9) , e23807
Abstract
Cancer is a deadly disease that affects a cell's metabolism and surrounding tissues. Understanding the fundamental mechanisms of metabolic alterations in cancer cells would assist in developing cancer treatment targets and approaches. From this perspective, metabolomics is a great analytical tool to clarify the mechanisms of cancer therapy as well as a useful tool to investigate cancer from a distinct viewpoint. It is a powerful emerging technology that detects up to thousands of molecules in tissues and biofluids. Like other “‐omics” technologies, metabolomics involves the comprehensive investigation of micromolecule metabolites and can reveal important details about the cancer state that is otherwise not apparent. Recent developments in metabolomics technologies have made it possible to investigate cancer metabolism in greater depth and comprehend how cancer cells utilize metabolic pathways to make the amino acids, nucleotides, and lipids required for tumorigenesis. These new technologies have made it possible to learn more about cancer metabolism. Here, we review the cellular and systemic effects of cancer and cancer treatments on metabolism. The current study provides an overview of metabolomics, emphasizing the current technologies and their use in clinical and translational research settings.Keywords
This publication has 197 references indexed in Scilit:
- Development of a gas chromatography–mass spectrometry method for breast cancer diagnosis based on nucleoside metabolomes 1‐methyl adenosine, 1‐methylguanosine and 8‐hydroxy‐2′‐deoxyguanosineBiomedical Chromatography, 2019
- CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis–Driven Hepatocarcinogenesis via ERK‐Dependent PKM2 Nuclear Relocalization and ActivationHepatology, 2019
- Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profileIUBMB Life, 2018
- How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013International Journal of Cancer, 2017
- Mass spectrometry imaging as a tool for surgical decision‐makingJournal of Mass Spectrometry, 2013
- Potential metabolomic biomarkers for evaluation of adriamycin efficacy using a urinary 1H‐NMR spectroscopyJournal of Applied Toxicology, 2012
- Targeted MetabolomicsCurrent Protocols in Molecular Biology, 2012
- The evolution of partial least squares models and related chemometric approaches in metabonomics and metabolic phenotypingJournal of Chemometrics, 2010
- Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomicsInternational Journal of Cancer, 2004
- An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck regionHead & Neck, 2002